Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Considers Making More Guidance Final Without Public Comment
Jan 04 2024
•
By
Derrick Gingery
To use the ‘immediately implementation’ provision, public comment has to be deemed not feasible or inappropriate. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from Pathways & Standards